Shannon M. Whitman, Program Administrator

What is new with the MN PMP?

Rural Opioid ECHO SeriesOctober 9, 2019

Objectives

• Look at the NEW AWARxE NarxCare Report

• Review when it is permissible to access PMP data in MN according to MN Stats. §152.126.

• Changes in legislation relating to authorized delegates that may be assisting health care providers

10/9/2019 Supporting Patient Care since 2010. | www.pmp.pharmacy.mn.us 2

Transition from RxSentry to AWARxE

• Important things that did notchange:

• Requirements for Reporting – MN Dispensers within 24 hours

• CFR2 – Opioid Treatment Programs do not report.

• Request Patient Report data from 42 jurisdictions outside of Minnesota

• No change to who can access the data and when

• NEW in AWARxE• Dynamic user-friendly dashboard

• Applied analytics generate:

• Risk scores

• Interactive graphs with point-and-click ease of use

• Treatment location finder

• Printable resources

10/9/2019 Supporting Patient Care since 2010. | www.pmp.pharmacy.mn.us 3

My Dashboard

1

2

3

NarxCare Report – Applied Analytics

1

2 3

4

Interactive Graphing

Summary and Line by Line Data

Linked to SAMSHSA database.

CDC InformationDocuments

Resources within

NarxCare

Daily Reporting• Pharmacies licensed in MN

• Out of state pharmacies licensed to dispense into MN

• Prescribers dispensing from their office (excluding veterinarians)

• Hospitals dispensing for outpatient use

• VA and IHS Facilities

10/9/2019 Supporting Patient Care Since 2010 | pmp.pharmacy.state.mn.us 9

Schedule II – V Controlled substances, butalbital, & gabapentin

OTP Data- Federal Rule

• The Confidentiality of Substance Use Disorder Patient Records (42 CFR part 2) prevent access to patient records for the treatment of SUD.

• OTP dispensations of MAT will not appear in the PMP report

10/9/2019 10Supporting Patient Care Since 2010 | pmp.pharmacy.state.mn.us

Proposed RulemakingIssued by HHS

Changes to the Confidentiality of SUD

Patient Records

Allows OTPs to report to PDMPs

Open for comment through October 25,

2019

https://www.regulations.gov/document?D=HHS-OS-2019-0011-0001

PMP InterConnect

11

42 States and Jurisdictionsas of October 2019

A provider may permissibly access PMP data for a current patient to whom the prescriber is:

prescribing or considering prescribing a controlled substance.

providing emergency medical treatment for which access to the data may be necessary.

providing care, and there is reason to believe, based on clinical indication, that the patient may be abusing a controlled

substance.

providing other medical treatment for which the data may be necessary for a clinical purpose and the patient has provided

consent.

12

OR

OR

OR

OR

New Legislation - Delegate Audits

• Communication sent via email to account holders September 23, 2019, first audit is to be completed by October 31 for Q2-2019 (July – Sept)

• If you have not granted access to any delegates: NO ACTION REQUIRED!

• Requirements: • Review patient reports generated by your delegates under your authority on a quarterly basis for permissible use.

• It is up to the provider or healthcare system to establish a process for tracking audits. (Printing a PDF of request history after review, attesting and submitting to supervisor, etc.)

• If a delegate is no longer authorized to access reports on your behalf, remove access within 3 business days. (No longer an employee).

• If a delegate has been found to have accessed patient PMP data impermissibly, remove access immediately and report access to the PMP staff within 7 calendar days. (Patient name, date of access, delegate name.)

Account holders should be prepared to account for their delegate(s) access to the PMP health data if there is a suspected breach or investigation by their health licensing board.

pmp.pharmacy@state.mn.us 13

Resources, help, and guides….pmp.pharmacy.state.mn.us

PMP Registration and ResourcesLogin or Create a New AWARxE Account

Support Guide

Quick Reference Guides

Delegate Management

NarxCare Tutorials

FAQsResourcesDelegate Auditing Information

Contact Us

From the MN PMP Home Page, click:

http://www.pmp.pharmacy.state.mn.us/pmp-user-registration-and-resources.html

MN PMP Program Contact

15

Minnesota Board of Pharmacy - Prescription Monitoring Program2829 University Avenue SE Suite 530Minneapolis, MN 55414

651.201.2836minnesota.pmp@state.mn

www.pmp.pharmacy.state.mn.us

mailto:minnesota.pmp@state.mn

Shannon M. Whitman, Program AdministratorObjectivesTransition from RxSentry to AWARxEMy DashboardNarxCare Report – Applied AnalyticsInteractive Graphing�Summary and Line by Line DataResources within NarxCareDaily ReportingOTP Data- Federal RulePMP InterConnectA provider may permissibly access PMP data for a current patient to whom the prescriber is: New Legislation - Delegate AuditsResources, help, and guides….�pmp.pharmacy.state.mn.usMN PMP Program Contact